Recombinant genomic RNA of coronavirus MHV-A59 after coreplication with a DI RNA containing the MHV-RI spike gene

Virology

Volumn 230, Issue 1, 1997, Pages 93-102

  Zhang, Linong ^a,b   Homberger, Felix ^b   Spaan, Willy ^a   Luytjes, Willem ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; DNA SEQUENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS RECOMBINATION; VIRUS REPLICATION;

ANIMALIA; CORONAVIRUS; MURINE HEPATITIS VIRUS; VACCINIA;

EID: 0031592616     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8460     Document Type: Article

References (49)

1. Banner L. R., Keck J. G., Lai M. M. C. A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology. 175:1990;548-555.
2. Banner L. R., Lai M. M. C. Random nature of coronavirus RNA recombination in the absence of selection pressure. Virology. 185:1991;441-445.
3. Barthold S. W. Mouse hepatitis virus biology and epizootiology. Viral and Mycoplasmal Infections of Laboratory Rodents. 1986;Academic Press, New York. p. 571-601.
4. Barthold S. W. Host age and genotypic effects on enterotropic mouse hepatitis virus infection. Lab. Anim. Sci. 37:1987;36-40.
5. Barthold S. W., Beck D. S., Smith A. L. Enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease. Lab. Anim. Sci. 43:1993;276-284.
6. Barthold S. W., Smith A. L., Povar M. L. Enterotropic mouse hepatitis virus infection in nude mice. Lab. Anim. Sci. 35:1985;613-618.
7. Carpenter C. D., Oh J-W., Zhang C., Simon A. E. Involvement of a stem-loop structure in the location of junction sites in viral RNA recombination. J. Mol. Biol. 245:1995;608-622.
8. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology. 119:1982.
9. Compton S. R., Barthold S. W., Smith A. L. The cellular and molecular pathogenesis of coronaviruses. Lab. Anim. Sci. 43:1993;15-28.
10. De Groot R. J., Van der Most R. G., Spaan W. J. M. The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations. J. Virol. 66:1992;5898-5905.
11. Dalziel R. G., Lampert P. W., Talbot P. J., Buchmeier M. J. Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. J. Virol. 59:1986;463-471.
12. Daniel C., Talbot P. J. Protection of mice from lethal coronavirus MHV-A59 infection by monoclonal affinity-purified spike glycoprotein. Cavanagh D., Brown T. D. K. Coronaviruses and Their Diseases. 1990;205-210 Plenum Press, New York.
13. Fazakerley J. K., Parker S. E., Bloom F., Buchmeier M. J. The V5A13.1. envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology. 187:1992;178-188.
14. Fleming J. O., Trousdale M. D., El-Zaatari F. A. K., Stohlman S. A., Weiner L. A. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J. Virol. 58:1986;869-875.
15. Hahn Y. S., Grakoui A., Rice C. M., Strauss E. G., Strauss J. H. Mapping of RNA-temperature-sensitive mutants of Sindbis virus: complementation group F mutants have lesions in nsP4. J. Virol. 63:1989a;1194-1202.
16. Hahn Y. S., Strauss E. G., Strauss J. H. Mapping of RNA-temperature-sensitive mutants of Sindbis virus: assignment of complementation groups A, B, and G to nonstructural proteins. J. Virol. 63:1989b;3142-3150.
17. Hasony H. J., Macnaughton M. R. Antigenicity of mouse hepatitis virus strain 3 subcomponents in C57 strain mice. Arch. Virol. 69:1981.
18. Hingley S. T., Gombold J. L., Lavi E., Weiss S. R. MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology. 200:1994;1-10.
19. Jarvis T. C., Kirkegaard K. The polymerase in its labyrinth: mechanisms and implications of RNA recombination. Trends Genet. 7:1991;186-191.
20. Keck J. G., Soe L. H., Markino S., Lai M. M. C. RNA recombination of murine coronavirus: recombination between fusion-positive mouse hepatitis virus A59 and fusion-negative mouse hepatitis virus. J. Virol. 62:1988;1989-1998.
21. Keck J. G., Stohlman S. A., Soe L. H., Makino S., Lai M. M. C. Multiple recombination sites at the 5′-end of murine coronavirus RNA. Virology. 156:1987;331-341.
22. Kirkegaard K., Baltimore D. The mechanism of RNA recombination in poliovirus. Cell. 47:1986;433-443.
23. Koetzner C. A., Parker M. M., Richard C. S., Sturman L. S., Masters P. S. Repair and mutagenesis of the genome of a deletion mutant of the coronavirus mouse hepatitis virus by targeted RNA recombination. J. Virol. 66:1992;1841-1848.
24. Kohara M., Omata T., Kameda A., Semler B. L., Itoh H., Wimmer E., Nomoto A. In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated sabin strain. J. Virol. 53:1985;786-792.
25. Kunita S., Zhang L., Homberger F. R., Compton S. R. Molecular characterization of the S proteins of two enterotropic murine coronavirus strains. Virus Res. 35:1995;277-289.
26. Lai M. M. C., Baric R. S., Makino S., Keck J. G., Egbert J., Leibowitz J. L., Stohlman S. A. Recombination between nonsegmented RNA genomes of murine coronavirus. J. Virol. 56:1985;449-456.
27. La Monica N., Meriam C., Racaniello V. C. Mapping of sequences required for mouse neurovirulence of poliovirus type 28 Lansing. J. Virol. 57:1986;515-525.
28. Langridge L., Langridge P., Bergquist P. L. Extraction of nucleic acids from agarose gels. Anal. Biochem. 103:1980;661-670.
29. Lustig S., Jackson A. C., Hahn C. S., Griffin D. E., Strauss E. G., Strauss J. H. Molecular basis of Sindbis virus neurovirulence in mice. J. Virol. 62:1988;2329-2336.
30. Luytjes W., Sturman L. S., Bredenbeek P. J., Charité J., Van der Zeijst B. A. M., Horzinek M. C., Spaan W. J. M. Primary structure of the glycoprotein E2 of coronavirus MHV-A59 and identification of the trypsin cleavage site. Virology. 161:1987;479-487.
31. Luytjes W., Gerritsma H., Spaan W. J. M. Replication of synthetic defective interfering RNAs derived from coronavirus mouse hepatitis virus-A59. Virology. 216:1996;174-183.
32. Makino S., Fleming J. O., Keck J. G., Stohlman S. A., Lai M. M. C. RNA recombination of coronavirus: location of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc. Natl. Acad. Sci. USA. 84:1987;6567-6571.
33. Makino S., Keck J. G., Stohlman S. A., Lai M. M. C. High-frequency RNA recombination of murine coronaviruses. J. Virol. 57:1986;729-737.
34. Makino S., Taguchi F., Fujiwara K. Defective interfering particles of mouse hepatitis virus. Virology. 133:1984;9-17.
35. Masters P. S., Koetzner C. A., Kerr C. A., Heo Y. Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J. Virol. 68:1994;328-337.
36. Meinkoth J., Wahl G. Hybridization of nucleic acids immobilized on solid supports. Anal. Biochem. 138:1984;267-284.
37. Nagy P. D., Bujarsky J. J. Efficient system of homologous RNA recombination in brome mosaic virus: sequence and structure requirements and accuracy of crossovers. J. Virol. 69:1995;2547-2556.
38. Nagy P. D., Bujarsky J. J. Homologous RNA recombination in brome mosaic virus: AU-rich sequences decrease the accuracy of crossovers. J. Virol. 70:1996;415-426.
39. Omata T., Kohara M., Kuge S., Komatsu T., Abe S., Semler B. L., Kameda A., Itoh H., Arita M., Wimmer E., Nomoto A. Genetic analysis of the attenuation phenotype of poliovirus type 1. J. Virol. 58:1986;348-358.
40. Peng D., Koetzner C. A., Masters P. S. Analysis of second-site revertants of a murine coronavirus nucleocapsid protein deletion mutant and construction of nucleocapsid protein mutants by targeted RNA recombination. J. Virol. 69:1995;3449-3457.
41. Pincus S. E., Wimmer E. Production of guanidine-resistant and dependent poliovirus mutants from cloned cDNA mutations in polypeptide 2c are directly responsible for altered guanidine sensitivity. J. Virol. 60:1986;793-796.
42. Romanova L. I., Blinov V. M., Tolskaya E. A., Viktorova E. G., Kolesnikova M. S., Guseva E. A., Agol V. I. The primary structure of crossover regions of intertypic poliovirus recombinants: a model of recombination between RNA genomes. Virology. 155:1986;202-213.
43. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
44. Spaan W. J. M., Rottier P. J. M., Horzinek M. C., Van der Zeijst B. A. M. Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59). Virology. 108:1981;424-434.
45. Tolskaya E. A., Romanova L. I., Blinov V. M., Viktorova E. G., Sinyakov A. N., Koleskinova M. S., Agol V. I. Studies on the recombination between RNA genomes of poliovirus: the primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants. Virology. 161:1987;54-61.
46. Van der Most R. G., Bredenbeek P. J., Spaan W. J. M. A domain at the 3′ end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J. Virol. 65:1991;3219-3226.
47. Van der Most R. G., Heijnen L., Spaan W. J. M., De Groot R. J. Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic co-replicating RNAs. Nucleic Acids Res. 13:1992;3375-3381.
48. Van der Most R. G., Rutjes S., Spaan W. J. M. Translation but not the encoded sequence is essential for the propagation of the defective interfering RNAs of the coronavirus mouse hepatitis virus. J. Virol. 69:1995;3744-3751.
49. Wege H., Winter J., Meyermann R. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. J. Gen. Virol. 69:1988;87-98.